-- 邁寶生物（上海）有限公司（港交所代號：2493，滬港通代號：688062）週二早盤在香港上市首日表現穩健，開盤價較首次公開發行（IPO）價格上漲2.4%。 這家總部位於中國的製藥公司以每股28.30港元開盤，高於其27.64港元的發行價。
Related Articles
Asia
Nomura Adjusts Eve Energy's Price Target to 100 Yuan from 91 Yuan, Keeps at Buy
Eve Energy (SHE:300014) has an average rating of buy and mean price target of 90.96 yuan, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$SHE:300014
Asia
Aneka Tambang Posts Higher Q1 Earnings, Revenue
Aneka Tambang (ASX:ATM) reported Tuesday first quarter earnings of 141.77 Indonesian rupiah per share, up from 88.69 rupiah a year earlier.Revenue for the three months ended March 31 was 29.323 trillion rupiah, compared with 26.152 trillion rupiah a year earlier.The company's shares rose 1% in recent Tuesday trade.
$ASX:ATM
Asia
Domino's Pizza Enterprises Shares Fall 10% After Q1 Results Miss Estimates
Domino's Pizza Enterprises (ASX:DMP) shares fell 10% in recent Tuesday trade after its first quarter earnings per share fell to $4.13 per share from $4.33 a year earlier.Analysts polled by FactSet expected EPS of $4.28.Revenue rose 3.5% to $1.15 billion, while analysts expected $1.16 billion."We now expect our international same-store sales growth to be low single-digits, primarily as a result of the macro and geopolitical uncertainty across the world," said Chief Financial Officer Sandeep Reddy during an earnings call, according to a FactSet transcript.
$ASX:DMP